🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study examines if Riluzole, FDA approved for ALS, will improve symptom...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2003-02
Trial ID
NCT00054704
The objective is to compare the efficacy and safety of masitinib in combina...
Status
Not Yet Recruiting
Location
Aiginition Hospital
Start Date
2026-01-01
Trial ID
NCT07174492
Treatments Being Tested
The objective of the study is to compare the pharmacokinetic profile of ril...
Status
Completed
Location
CROSS Research SA Phase 1 Unit
Start Date
2021-01-15
Trial ID
NCT04819438
Treatments Being Tested
The goal of the current proposal is to examine if sublingual riluzole can r...
Status
Completed
Location
Connecticut Mental Health Center
Start Date
2017-01
Trial ID
NCT03017508
Y-4 is a new fixed-dose combination drug product containing two active ingr...
Status
Recruiting
Location
Beijing Tiantan Hospital, Capital Medical University Beijing
Start Date
2025-05-19
Trial ID
NCT07013773
Treatments Being Tested
The objective is to compare the efficacy and safety of masitinib in combina...
Status
Completed
Location
Hospital Carlos III
Start Date
2013-04
Trial ID
NCT02588677
Treatments Being Tested
The primary goal of this clinical trial is to compare pharmacokinetic chara...
Status
Not Yet Recruiting
Location
Frontage Clinical Services,Inc.
Start Date
2026-06-30
Trial ID
NCT07618715
Treatments Being Tested
This is a single center, randomized, double-blind, placebo-controlled, 6-mo...
Status
Completed
Location
Carolinas Healthcare System, Dept. of Neurology
Start Date
2014-09
Trial ID
NCT02238626
Treatments Being Tested
RATIONALE: Studying samples of tumor tissue and blood from patients with ca...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-05
Trial ID
NCT00903214